bromodeoxyuridine has been researched along with Cystadenocarcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izutsu, T; Kagabu, T; Kaneko, S; Matsuda, M; Nishiya, I; Yoshizaki, A | 1 |
| Hirama, T; Izutsu, T; Kagabu, T; Matsuda, M; Nishiya, I; Sato, K; Sato, M; Yokosuka, K; Yoshizaki, A; Yoshizumi, N | 1 |
| Fukuda, K; Hachisuga, T; Hayashi, Y; Iwasaka, T; Sugimori, H | 1 |
3 other study(ies) available for bromodeoxyuridine and Cystadenocarcinoma
| Article | Year |
|---|---|
Appreciation for malignancy on ovarian neoplasm by monoclonal antibody of BrdUrd.
Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Bromodeoxyuridine; Cystadenocarcinoma; DNA, Neoplasm; Female; Flow Cytometry; Humans; Immunohistochemistry; Middle Aged; Ovarian Neoplasms; Teratoma | 1988 |
[DNA synthetic cell analysis by monoclonal antibody of bromodeoxyuridine in patients with endometrial carcinoma].
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; Cystadenocarcinoma; DNA, Neoplasm; Female; Humans; Interphase; Tumor Cells, Cultured; Uterine Neoplasms | 1988 |
Immunocytochemical detection of S-phase cells in gynecologic malignancies using anti-BrdU monoclonal antibody.
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cystadenocarcinoma; Female; Genital Neoplasms, Female; Humans; Immunohistochemistry; Interphase; Ovarian Neoplasms; Uterine Cervical Neoplasms | 1988 |